Kristina Broadbelt
Director of Global Patient Advocacy
Raptor Pharmaceuticals
Q1 Productions is proud to have Kristina Broadbelt of Raptor Pharmaceuticals join the presenter lineup at the 5th Annual Strengthening Patient Advocacy Relations Conference, July 14-15, 2016 in Baltimore, Maryland.
Broadbelt has more than 20 years’ experience in healthcare communications, public affairs and stakeholder relations across pharmaceutical, biotechnology, medical device and medical service companies. Starting her career in consulting, she transitioned to industry a decade ago with a focus on “patient-partnered” care. Most recently, Broadbelt built the global advocacy function for ViroPharma Incorporated, a rare disease biotech acquired by Shire in 2014. Currently, she is the Director of Global Patient Advocacy for Raptor Pharmaceuticals, an emerging global biopharmaceutical company focused on developing and commercializing life-altering therapeutics that treat rare, debilitating and often fatal diseases.
